About Lytix Biopharma
We are a clinical-stage biotechnology company developing first-in-class oncolytic molecule immunotherapies for the treatment of cancer. Our mission is to redefine the standard of care and improve patient outcomes.
Meet Our Team
Management Team
Meet our leadership team driving innovation in oncology and bringing transformative therapies to patients.
Board of Directors
Strategic guidance from industry experts with deep experience in biopharma and healthcare.
Scientific Advisory Board
World-class clinical expertise shaping our research and development programs.
Driven by Purpose
At Lytix Biopharma, we believe that breakthrough science can transform the lives of cancer patients. Our commitment to innovation drives everything we do.
Mission-Driven
Developing first-in-class therapies to transform cancer treatment.
Scientific Excellence
Pioneering oncolytic molecule immunotherapy research.
Patient-Focused
Everything we do is for the patients who need new treatment options.
Ready to learn more about Lytix?
Connect with our team to discuss partnership opportunities, clinical programs, or investor relations.